Patents by Inventor Patricia Kane
Patricia Kane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11129842Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: GrantFiled: October 3, 2018Date of Patent: September 28, 2021Assignee: BODYBIO INCInventors: Edward Kane, Patricia Kane, Brett T Hauser
-
Publication number: 20200108082Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: ApplicationFiled: October 3, 2018Publication date: April 9, 2020Applicant: BODYBIO INC.Inventors: Edward Kane, Patricia Kane, Brett T. Hauser
-
Patent number: 10117883Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: GrantFiled: July 11, 2017Date of Patent: November 6, 2018Assignee: BODYBIO INC.Inventors: Edward Kane, Patricia Kane, Brett T. Hauser
-
Patent number: 10052339Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: GrantFiled: March 1, 2015Date of Patent: August 21, 2018Assignee: BODYBIO INC.Inventors: Edward Kane, Patricia Kane, Brett T Hauser
-
Publication number: 20170319607Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: ApplicationFiled: July 11, 2017Publication date: November 9, 2017Applicant: BODYBIO INC.Inventors: EDWARD KANE, PATRICIA KANE, BRETT T. HAUSER
-
Patent number: 9655910Abstract: This invention relates to compositions containing combinations of a balanced PC composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from addiction to substances and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: GrantFiled: March 1, 2015Date of Patent: May 23, 2017Assignee: BODYBIO INC.Inventors: Edward Kane, Patricia Kane, Brett T Hauser
-
Publication number: 20150265636Abstract: This invention relates to compositions containing combinations of a balanced PC composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from addiction to substances and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: ApplicationFiled: March 1, 2015Publication date: September 24, 2015Applicant: BODYBIO INC.Inventors: Edward Kane, Patricia Kane, Brett T. Hauser
-
Publication number: 20150265637Abstract: This invention relates to compositions containing combinations of a balanced phosphatidylcholine composition and one or more cannabinoids, a natural or synthetic derivative thereof, or a salt thereof, and kits containing such combinations and methods of using such combinations to treat subjects suffering from an imbalance of fatty acids and related diseases or disorders. This invention also relates to the synergistic effect of such combination therapies in humans.Type: ApplicationFiled: March 1, 2015Publication date: September 24, 2015Applicant: BODYBIO INC.Inventors: EDWARD KANE, PATRICIA KANE, BRETT T. HAUSER
-
Publication number: 20150080403Abstract: The invention as disclosed herein provides pharmaneutical compositions and methods for treating, ameliorating, or preventing the symptoms of Parkinson's Disease. The pharmaneutical compositions of the invention contain in an effective amount a first and a second composition, the first composition comprises an effective amount of one or more phosphatidylcholine formulations and the second composition comprises an effective amount of one or more constituents comprising essential fatty acid supplements, trace minerals, butyrate, electrolytes, methylating agents, reduced glutathione, or a combination thereof, in a suitable carrier.Type: ApplicationFiled: July 21, 2014Publication date: March 19, 2015Applicant: NEUROLIPID RESEARCH FOUNDATION, INCInventors: PATRICIA KANE, EDWARD KANE
-
Patent number: 8000982Abstract: The present invention provides networks and method for linking consumers and nutritional pharmacogeneticists offering personalized nutritional information through a central network site. The network includes a central integration site through which network members communicate with each other. The central integration site stores two or more databases in the storage medium. The databases store biochemical marker data information, nutritional and/or drug data information including a record for association and effect of nutrients with a particular biochemical marker, and/or drug. The network of the invention provides individualized nutritional diagnostic and treatment to consumers on the basis of their genetic test results.Type: GrantFiled: March 19, 2008Date of Patent: August 16, 2011Assignee: Body Bio, Inc.Inventors: Edward Kane, Patricia Kane
-
Publication number: 20100022444Abstract: The invention as disclosed herein provides methods and compositions for modulation of development and activities of cells and tissues in a subject in need of treatment thereof. The inventive methods and compositions involve the use of a combination therapy that comprises at least two active compositions, the first active composition comprising a balanced PC and an essential fatty acid composition and the second active composition comprising a growth factor, in a suitable carrier or diluent, wherein the combination therapy modulates development and activities of cells and tissues in the subject.Type: ApplicationFiled: July 24, 2009Publication date: January 28, 2010Applicant: BodyBio, Inc.Inventors: Patricia Kane, Edward Kane
-
Patent number: 7645795Abstract: The administration of nutritional supplements such as phosphatidylcholine; linoleic acid and alpha linolenic acid in an approximately 4:1 (v/v) ratio; and mineral supplements provides an effective method for the treatment of ALS. Subjects presenting with symptoms indicative of ALS can therefore be treated with these nutritional supplements to inhibit progression of ALS. Subjects at risk for developing ALS can also be treated with these nutritional supplements to delay the onset of ALS symptoms.Type: GrantFiled: September 21, 2004Date of Patent: January 12, 2010Assignee: BodyBio, IncInventors: Patricia Kane, Edward Kane
-
Publication number: 20080254017Abstract: The invention as disclosed herein provides pharmaneutical compositions and methods for treating, ameliorating, or preventing the symptoms of fatty acids imbalance and cell membrane dysfunction. The pharmaneutical compositions of the invention contain in an effective amount a first and a second composition, the first composition comprises an effective amount of one or more phosphatidylcholine formulations and the second composition comprises an effective amount of one or more constituents comprising essential fatty acid supplements, trace minerals, phenylbutyrate, electrolytes, methylating agents, reduced glutathione, or a combination thereof, in a suitable carrier.Type: ApplicationFiled: June 19, 2006Publication date: October 16, 2008Applicant: BodyBio, Inc.Inventors: Patricia Kane, Edward Kane
-
Publication number: 20080221932Abstract: The present invention provides networks and method for linking consumers and nutritional pharmacogeneticists offering personalized nutritional information through a central network site. The network includes a central integration site through which network members communicate with each other. The central integration site stores two or more databases in the storage medium. The databases store biochemical marker data information, nutritional and/or drug data information including a record for association and effect of nutrients with a particular biochemical marker, and/or drug. The network of the invention provides individualized nutritional diagnostic and treatment to consumers on the basis of their genetic test results.Type: ApplicationFiled: March 19, 2008Publication date: September 11, 2008Applicant: BodyBio, Inc.Inventors: Edward Kane, Patricia Kane
-
Publication number: 20080145506Abstract: The invention discloses food products and compositions containing a fat content, wherein the fat content has been enriched, supplemented, and/or substituted, partially or totally, with a pre-determined balanced ratio of an omega 6 and an omega 3 essential fatty acid.Type: ApplicationFiled: December 18, 2006Publication date: June 19, 2008Applicant: BodyBio, Inc.Inventors: Edward Kane, Patricia Kane
-
Publication number: 20070042008Abstract: The invention discloses pharmaneutical compositions comprising a phospholipid formulation that is fluidized with an oil composition containing a pre-determined ratio of omega 6 and omega 3 fatty acids. In particular the invention discloses phosphatidylcholine compositions that are fluidized with a pre-determined ratio of linoleic acid and alpha linolenic acid.Type: ApplicationFiled: August 18, 2005Publication date: February 22, 2007Applicant: BodyBio, Inc.Inventors: Edward Kane, Patricia Kane
-
Publication number: 20070004639Abstract: The invention as disclosed herein provides pharmaneutical compositions and methods for treating, ameliorating, or preventing the symptoms of Parkinson's Disease. The pharmaneutical compositions of the invention contain in an effective amount a first and a second composition, the first composition comprises an effective amount of one or more phosphatidylcholine formulations and the second composition comprises an effective amount of one or more constituents comprising essential fatty acid supplements, trace minerals, butyrate, electrolytes, methylating agents, reduced glutathione, or a combination thereof, in a suitable carrier.Type: ApplicationFiled: July 1, 2005Publication date: January 4, 2007Applicant: BodyBio, Inc.Inventors: Patricia Kane, Edward Kane
-
Publication number: 20050019423Abstract: The administration of nutritional supplements such as phosphatidylcholine; linoleic acid and alpha linoleic acid in an approximately 4:1 (v/v) ratio; and mineral supplements provides an effective method for the treatment of ALS. Subjects presenting with symptoms indicative of ALS can therefore be treated with these nutritional supplements to inhibit progression of ALS. Subjects at risk for developing ALS can also be treated with these nutritional supplements to delay the onset of ALS symptoms.Type: ApplicationFiled: September 21, 2004Publication date: January 27, 2005Applicant: BodyBio CorporationInventors: Patricia Kane, Edward Kane
-
Patent number: 6063026Abstract: The present invention is a computerized medical diagnostic method. It includes a first database containing a correlation of a plurality of diseases with a plurality of indicators associated with each such disease. A second database includes human experience test results associated with each indicator. An individual's test results are then compared with the second database data to determine presence levels for each indicator. Thereafter the presence levels are compared with the data in the first database to provide a pattern matching determination of diseases associated with the various indicator presence levels.The presence level indicators for an individual may be affected by many environmental and/or personal factors such as age, sex, race, pregnancy, residence location, previous or current diseases, previous or current drug usage, etc., all of which are factors to be considered in creating an accurate analysis system.Type: GrantFiled: March 22, 1996Date of Patent: May 16, 2000Assignee: Carbon Based CorporationInventors: Mark A. Schauss, Patricia Kane